Chat with us, powered by LiveChat
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

The India osteoarthritis therapeutics market was valued at USD 382.20 Million in 2024, driven by factors such as increasing healthcare awareness, rising osteoarthritis prevalence, and improvements in treatment options across the region. The market is expected to grow at a robust CAGR of 5.40% from 2025 to 2034, with projected values reaching USD 646.69 Million by 2034. This growth reflects the expansion of healthcare infrastructure, advancements in therapeutics, and a growing demand for effective osteoarthritis treatments across the country.

2024

Base Year

2018-2024

Historical Period

2025-2034

Forecast Period

  • In March 2025, Dr. Reddy’s partnered with Bio-Thera to commercialize Stelara and Simponi biosimilars in Southeast Asia, potentially expanding biosimilar access for osteoarthritis treatment across emerging markets, including India.

  • A key trend in the India osteoarthritis therapeutics market is the rise of muscle-centric treatments. In January 2025, OPTM Healthcare's New Delhi clinic introduced AI-based diagnostics and phyto-topical therapies targeting joint degeneration and muscle health.

  • The rising prevalence of osteoarthritis in India is driving demand for effective therapeutics. Innovations in drug formulations and increasing healthcare access are also expected to propel market growth in the forecast period.

Compound Annual Growth Rate

Value in USD Million

5.4%

2025-2034


India Osteoarthritis Therapeutics Market Outlook

*this image is indicative*

India Osteoarthritis Therapeutics Market Overview

Osteoarthritis therapeutics encompass a range of treatment approaches, including analgesics, nonsteroidal anti-inflammatory drugs, physical therapy, lifestyle modifications, and surgical options, to alleviate joint pain, enhance mobility, and slow disease progression. In India, the osteoarthritis therapeutics market is poised to grow at a CAGR of 5.40% during the forecast period of 2025–2034, due to the increasing elderly population, sedentary lifestyles, obesity, and greater awareness of early diagnosis.

India Osteoarthritis Therapeutics Market Growth Drivers

High Osteoarthritis Prevalence to Accelerate Therapeutics Market Growth in India

A major growth driver in the market in India is the increasing prevalence of osteoarthritis, particularly among the aging and obese population. According to a study published by the National Institutes of Health (NIH) in March 2024, multiple studies across India reported osteoarthritis prevalence rates ranging from 20% to 40%. This significant and growing disease burden is expected to boost demand for effective treatment solutions, thereby driving sustained market expansion in the coming years.

India Osteoarthritis Therapeutics Market Trends

India Osteoarthritis Therapeutics Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Type

  • Hip Osteoarthritis
  • Spinal Osteoarthritis
  • Knee Osteoarthritis
  • Hand Osteoarthritis
  • Others

Market Breakup by Drug Class

  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Other Analgesics
  • Corticosteroids
  • Hyaluronic Acid Injections
  • Others

Market Breakup by Dosage Form

  • Tablets and Capsules
  • Injections
  • Creams and Gels
  • Others

Market Breakup by Route of Administration

  • Oral
  • Parenteral
  • Topical

Market Breakup by End User

  • Hospitals
  • Specialty Clinics
  • Homecare Settings
  • Others

Market Breakup by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

India Osteoarthritis Therapeutics Market Share

NSAIDs to Account for a Significant Share for Segmentation by Drug Classes

The market, based on drug class, is divided into nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, other analgesics, hyaluronic acid injections, and others. NSAIDs are expected to dominate due to their proven efficacy in pain and inflammation management. Their accessibility, affordability, and role as a primary line of treatment make them the most utilized drug category in osteoarthritis therapeutics across the Indian pharmaceutical landscape.

Leading Players in the India Osteoarthritis Therapeutics Market

The key features of the market report comprises epidemiology, clinical trials analysis, patent analysis, grant analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Sun Pharmaceutical Industries Ltd.

Headquartered in Mumbai, India, Sun Pharmaceutical Industries Ltd. was established in 1983. The company is actively involved in the osteoarthritis therapeutics market, notably through its MM-II candidate. This treatment has shown promising results in clinical trials, offering durable pain relief for knee osteoarthritis patients. The Phase 2b study demonstrated significant improvements, positioning MM-II as a potential alternative to existing treatments.

Dr. Reddy’s Laboratories

Dr. Reddy's Laboratories, established in 1984 and headquartered in Hyderabad, India, is a leading pharmaceutical company. In the osteoarthritis market, it has launched Hyalosyn, an intra-articular sodium hyaluronate injection aimed at providing relief for knee joint stiffness and immobility. Developed in collaboration with Gland Pharma, Hyalosyn addresses the growing demand for arthritis therapies in India, positioning Dr. Reddy’s as a key contributor to the market.

Cipla Ltd.

Cipla Limited, established in 1935 and headquartered in Mumbai, India, is a leading global pharmaceutical company. It has been actively involved in the India osteoarthritis therapeutics market, received approval for its generic version of Diclofenac sodium topical gel (1%), a therapeutic equivalent to Voltaren gel. This non-steroidal anti-inflammatory drug (NSAID) provides pain relief for osteoarthritis of joints such as the knees and hands, catering to the growing demand in India for affordable treatments.

Zydus Lifesciences Ltd.

Headquartered in Ahmedabad, India, and established in 1952, Zydus Lifesciences Limited has strengthened its presence in the market with the USFDA approval for its Ibuprofen and Famotidine Tablets (800 mg/26.6 mg) in February 2025. Indicated for osteoarthritis and rheumatoid arthritis, this formulation helps manage symptoms while reducing gastrointestinal risks. Produced at its Ahmedabad facility, the approval reflects Zydus's expanding therapeutic portfolio and growing global and domestic influence in musculoskeletal treatment solutions.

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Other key players in the market include Aurobindo Pharma Ltd., Troikaa Pharmaceuticals Ltd., Meril Life Sciences Pvt. Ltd., and Lupin Ltd.

Key Questions Answered in the India Osteoarthritis Therapeutics Market Report

  • What was the India osteoarthritis therapeutics market value in 2024?
  • What is the India osteoarthritis therapeutics market forecast outlook for 2025-2034?
  • What are the major factors aiding the India osteoarthritis therapeutics market demand?
  • How has the market performed so far, and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints?
  • What are the major India osteoarthritis therapeutics market trends?
  • Which type is expected to dominate the market segment?
  • Which drug class is projected to lead the market segment?
  • Which dosage form is projected to lead the market segment?
  • Which route of administration is anticipated to drive the market segment?
  • Which end user is anticipated to drive the market segment?
  • Which distribution channel is likely to dominate the market segment?
  • Who are the key players involved in the India osteoarthritis therapeutics market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2024
Historical Period 2018-2024
Forecast Period 2025-2034
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Drug Class
  • Dosage Form
  • Route of Administration
  • End User
  • Distribution Channel
Breakup by Type
  • Hip Osteoarthritis
  • Spinal Osteoarthritis
  • Knee Osteoarthritis
  • Hand Osteoarthritis
  • Others
Breakup by Drug Class
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Other Analgesics
  • Corticosteroids
  • Hyaluronic Acid Injections
  • Others
Breakup by Dosage Form
  • Tablets and Capsules
  • Injections
  • Creams and Gels
  • Others
Breakup by Route of Administration
  • Oral
  • Parenteral
  • Topical
Breakup by End User
  • Hospitals
  • Specialty Clinics
  • Homecare Settings
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • PESTEL Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Company News and Developments
    • Certifications
Companies Covered
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy’s Laboratories
  • Cipla Ltd.
  • Zydus Lifesciences Ltd.
  • Aurobindo Pharma Ltd.
  • Troikaa Pharmaceuticals Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • Lupin Ltd.

Datasheet

10 % Off

USD

1,999

1,799

Single User License

10 % Off

USD

3,099

2,789

Five User License

15 % Off

USD

4,599

3,909

Corporate License

15 % Off

USD

5,999

5,099

Datasheet

One User

USD 1,999

USD 1,799

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 3,099

USD 2,789

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 4,599

USD 3,909

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 5,999

USD 5,099

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-723-689-1189

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-723-689-1189

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

OSZAR »